Results 51 to 60 of about 9,172,807 (336)
Hospitalization rates for pneumococcal disease in Brazil, 2004 - 2006
Revista de Saúde Pública, 2011 OBJECTIVE: To estimate hospitalization rates for pneumococcal disease based on the Brazilian Hospital Information System (SIH). METHODS: Descriptive study based on the Hospital Information System of Brazilian National Health System data from January 2004
Hillegonda Maria Dutilh Novaes +2 more
doaj +1 more source
Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
Pneumonia, 2023 Background Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates (IRs) in ...
Salini Mohanty +6 more
doaj +1 more source
Invasive pneumococcal disease in relation to vaccine type serotypes
Human Vaccines & Immunotherapeutics, 2019 Since 1983 the world has been introduced to four vaccines combating disease caused by Streptococcus pneumoniae bacteria. However, despite vaccination programs disease caused by S.
Paeton L. Wantuch, F. Avci
semanticscholar +1 more source
Burden of Invasive Pneumococcal Disease
Clinical Infectious Diseases, 2019 TO THE EDITOR—We read with interest the article by Kent et al [1]. The authors note that the burden of invasive pneumococcal disease (IPD) in UK infants aged
Slack, Mary +6 more
openaire +4 more sources
Regulation of naturally acquired mucosal immunity to Streptococcus pneumoniae in healthy Malawian adults and children. [PDF]
PLoS ONE, 2012 Worldwide, invasive pneumococcal disease caused by Streptococcus pneumoniae is most common in young children. In adults, disease rates decline following intermittent colonization and the acquisition of naturally acquired immunity.
Sarah J Glennie +5 more
doaj +1 more source
Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil. [PDF]
, 2017 BackgroundPneumococcal conjugate vaccines (PCVs) are being used worldwide. A key question is whether the impact of PCVs on pneumonia is similar in low- and high-income populations.
Kürüm, Esra +7 more
core +2 more sources
PLoS ONE, 2017 Background Routine vaccination of elderly people against pneumococcal diseases is recommended in many countries. National guidelines differ, recommending either the 23-valent polysaccharide vaccine (PPV23), the 13-valent conjugate vaccine (PCV13) or both.
G. Falkenhorst +5 more
semanticscholar +1 more source
The remaining challenges of pneumococcal disease in adults [PDF]
European Respiratory Review, 2012 Pneumococcal disease can be divided into invasive disease, i.e. when bacteria are detected in normally sterile body fluids, and noninvasive disease. Pneumococcal disease occurs more frequently in younger children and older adults.
E. Ludwig +4 more
doaj
Emerging Microbes and Infections, 2021 Few studies on adult pneumococcal septic arthritis are sufficiently large enough to assess both epidemiological trends following routine pneumococcal immunization and clinical disease. With major shifts in serotypes causing invasive pneumococcal disease (
Catherine Hyams +7 more
doaj +1 more source
BMC Infectious Diseases, 2018 BackgroundDespite the widespread availability of pneumococcal vaccines, rates of pneumococcal disease are disproportionately high in adults with chronic and immunocompromising conditions.
Dongmu Zhang, T. Petigara, Xiaoqin Yang
semanticscholar +1 more source